922 related articles for article (PubMed ID: 26334205)
1. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
2. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
3. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
Kibria G; Hatakeyama H; Harashima H
Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
[TBL] [Abstract][Full Text] [Related]
6. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
Beretta GL; Cavalieri F
Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
[TBL] [Abstract][Full Text] [Related]
7. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
[TBL] [Abstract][Full Text] [Related]
8. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
9. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance?
Mercado-Lubo R; McCormick BA
Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607
[No Abstract] [Full Text] [Related]
10. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
Yin Q; Shen J; Zhang Z; Yu H; Li Y
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine: the promise and challenges in cancer chemotherapy.
Naguib YW; Cui Z
Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
[No Abstract] [Full Text] [Related]
13. Rationally designed nanovehicles to overcome cancer chemoresistance.
Livney YD; Assaraf YG
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1716-30. PubMed ID: 23954781
[TBL] [Abstract][Full Text] [Related]
14. Particle carriers for combating multidrug-resistant cancer.
Yan Y; Björnmalm M; Caruso F
ACS Nano; 2013 Nov; 7(11):9512-7. PubMed ID: 24215340
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.
Jia L; Li Z; Shen J; Zheng D; Tian X; Guo H; Chang P
Int J Pharm; 2015 Jul; 489(1-2):318-30. PubMed ID: 25956050
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine to overcome cancer multidrug resistance.
Yang X; Yi C; Luo N; Gong C
Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
[TBL] [Abstract][Full Text] [Related]
19. Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles.
Qin M; Lee YE; Ray A; Kopelman R
Macromol Biosci; 2014 Aug; 14(8):1106-15. PubMed ID: 24771682
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine therapeutic approaches to overcome cancer drug resistance.
Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]